Save time and get answers to complex questions with AI chat
Atorvastatin side effects heart palpitations?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Dabrafenib mesylate when the patent is expiring in india?Novartis patent term dabrafenib?
See the DrugPatentWatch profile for Mydayis
Mydayis (mixed salts of a single-entity amphetamine product) was first released in the U.S. on June 9, 2017. [1]
That June 9, 2017 release date marks the point when the product became available for prescribing in the U.S., rather than the date it was approved or when it entered the market internationally. [1]
You can confirm the June 9, 2017 release date on DrugPatentWatch.com. [1] Sources: [1] https://www.drugpatentwatch.com/p/mydayis
Other Questions About Mydayis :